Yüklüyor......
5-azacitidine prolongs overall survival in patients with myelodysplastic syndrome - a systematic review and meta-analysis
Hypomethylating agents have recently been shown to improve the outcome of patients with myelodysplastic syndrome. A meta-analysis and systematic review was carried out of randomized controlled trials comparing treatment with hypomethylating agents to conventional care, i.e., best supportive care or...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Ferrata Storti Foundation
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2817034/ https://ncbi.nlm.nih.gov/pubmed/19773261 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.010611 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|